Outcomes of periprocedural continuation vs interruption of oral anticoagulation in transcatheter aortic valve replacement

doi:10.4330/wjc.v17.i3.104000

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

HTML

Figures (1-2)

Tables (1-1)

Sum=6

Mar 26, 2025 (publication date) through Mar 21, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Cardiol. Mar 26, 2025; 17(3): 104000
Published online Mar 26, 2025. doi: 10.4330/wjc.v17.i3.104000

Open in New Tab Full Size Figure Download Figure

Figure 1 Preferred Reporting Items for Systematic Review and Meta-Analysis flow chart outlining literature search.

Open in New Tab Full Size Figure Download Figure

Figure 2 Forest plot. A: Forest plot of stroke among patients undergoing continuation vs interruption of oral anticoagulant (OAC) during transcatheter aortic valve replacement (TAVR); B: Forest plot of major vascular complication among patients undergoing continuation vs interruption of OAC during TAVR; C: Forest plot of bleeding among patients undergoing continuation vs interruption of OAC during TAVR; D: Forest plot of all-cause mortality among patients undergoing continuation vs interruption of OAC during TAVR.

Citation: Goyal A, Shoaib A, Fareed A, Jawed S, Khan MT, Salim N, Zameer U, Siddiqui A, Thakur T, Sulaiman SA. Outcomes of periprocedural continuation vs interruption of oral anticoagulation in transcatheter aortic valve replacement. World J Cardiol 2025; 17(3): 104000
URL: https://www.wjgnet.com/1949-8462/full/v17/i3/104000.htm
DOI: https://dx.doi.org/10.4330/wjc.v17.i3.104000